Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study

Millgate, Edward, Smart, Sophie E. ORCID: https://orcid.org/0000-0002-6709-5425, Pardinas, Antonio F. ORCID: https://orcid.org/0000-0001-6845-7590, Kravariti, Eugenia, Ajnakina, Olesya, Kepinska, Adrianna P., Andreassen, Ole A., Barnes, Thomas R.E., Berardi, Domenico, Crespo-Facorro, Benedicto, D'Andrea, Giuseppe, Demjaha, Arsime, Di Forti, Marta, Doody, Gillian A., Ucok, Alp, Kassoumeri, Laura, Ferchiou, Aziz, Guidi, Lorenzo, Joyce, Eileen M., Lastrina, Ornella, Melle, Ingrid, Pignon, Baptiste, Richard, Jean-Romain, Simonsen, Carmen, Szöke, Andrei, Tarricone, Ilaria, Tortelli, Andrea, Vázquez-Bourgon, Javier, Murray, Robin M., Walters, James T.R. ORCID: https://orcid.org/0000-0002-6980-4053 and MacCabe, James H. 2023. Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study. Schizophrenia Research 255 , pp. 173-181. 10.1016/j.schres.2023.03.020

	PDF - Published Version Available under License Creative Commons Attribution. Download (533kB)
Preview	PDF (Corrigendum) - Supplemental Material Available under License Creative Commons Attribution. Download (323kB) | Preview

Abstract

Background Antipsychotic treatment resistance affects up to a third of individuals with schizophrenia, with recent research finding systematic biological differences between antipsychotic resistant and responsive patients. Our aim was to determine whether cognitive impairment at first episode significantly differs between future antipsychotic responders and resistant cases. Methods Analysis of data from seven international cohorts of first-episode psychosis (FEP) with cognitive data at baseline (N = 683) and follow-up data on antipsychotic treatment response: 605 treatment responsive and 78 treatment resistant cases. Cognitive measures were grouped into seven cognitive domains based on the pre-existing literature. We ran multiple imputation for missing data and used logistic regression to test for associations between cognitive performance at FEP and treatment resistant status at follow-up. Results On average patients who were future classified as treatment resistant reported poorer performance across most cognitive domains at baseline. Univariate logistic regressions showed that antipsychotic treatment resistance cases had significantly poorer IQ/general cognitive functioning at FEP (OR = 0.70, p = .003). These findings remained significant after adjusting for additional variables in multivariable analyses (OR = 0.76, p = .049). Conclusions Although replication in larger studies is required, it appears that deficits in IQ/general cognitive functioning at first episode are associated with future treatment resistance. Cognitive variables may be able to provide further insight into neurodevelopmental factors associated with treatment resistance or act as early predictors of treatment resistance, which could allow prompt identification of refractory illness and timely interventions.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Additional Information:	This paper has a corrigendum: see related URL link
Publisher:	Elsevier
ISSN:	0920-9964
Related URLs:	https://doi.org/10.1016/j.schres.2024.06...
Date of First Compliant Deposit:	12 April 2023
Date of Acceptance:	11 March 2023
Last Modified:	19 Dec 2024 14:39
URI:	https://orca.cardiff.ac.uk/id/eprint/158538

Actions (repository staff only)

Edit Item